Jill Koshiol, Ph.D.
|Organization:||National Cancer InstituteDivision of Cancer Epidemiology & Genetics, Infections and Immunoepidemiology Branch|
|Address:||Executive Plaza SouthRoom 7070|
Dr. Jill Koshiol received her Ph.D. in epidemiology from the University of North Carolina at Chapel Hill School of Public Health in 2005. Subsequently, she joined the Genetic Epidemiology Branch of the Division of Cancer Epidemiology and Genetics as a Cancer Prevention Fellow. There, she focused on the role of human papillomavirus (HPV) in upper gastrointestinal and lung cancer, as well as infection- and immune-related conditions in lung and hematopoietic cancers. Dr. Koshiol joined the Infections and Immunoepidemiology Branch as a Research Fellow in 2008 and became an Earl Stadtman Tenure-Track Investigator in 2010.
In addition to her continued interest in investigating the epidemiology of infectious agents and cancer, Dr. Koshiol is increasingly interested in the role of immune stimulation and inflammation in carcinogenesis. Infection elicits both immune and inflammatory responses. Measuring infection and immune and inflammatory responses in biological specimens can provide novel insights into carcinogenesis, identify molecular subtypes of cancer, and identify potential associations with cancer outcomes.
Given the growing interest in the role of chronic inflammation and immune stimulation in carcinogenesis, Dr. Koshiol has examined the association of lung cancer with self-reported lung diseases, such as chronic obstructive pulmonary disease and pneumonia. She has also conducted records-based studies of immune-related conditions and non-Hodgkin lymphoma. Many of Dr. Koshiol’s planned studies expand on this interest by applying biological markers of immunity. By clarifying the role of infections, immune stimulation, and inflammation in carcinogenesis, Dr. Koshiol hopes to elucidate etiologic mechanisms and aid cancer prevention through the identification of cancer-related molecular pathways and targets.